| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 289,901 | 293,223 | 294,035 | 316,396 | | Cost of Revenue | 213,209 | 214,752 | 216,340 | 235,995 | | | Gross Profit | 76,692 | 78,471 | 77,695 | 80,401 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 62,023 | 62,251 | 68,385 | 68,084 | | Non Recurring | 40 | 53 | (93) | (127) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,666 | 16,167 | 9,403 | 12,444 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 86 | (1,082) | (202) | (381) | | Earnings Before Interest And Taxes | 10,806 | 15,085 | 9,201 | 12,063 | | Interest Expense | (1,969) | 865 | 1,104 | 1,477 | | Income Before Tax | 12,775 | 14,220 | 8,097 | 10,586 | | Income Tax Expense | 3,151 | 4,826 | 2,721 | 3,967 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,624 | 9,394 | 5,376 | 6,619 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 169 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,624 | 9,394 | 5,376 | 6,788 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,624 | $9,394 | $5,376 | $6,788 |
|
0.29% Nasdaq 0.00%
Income Statement
